ArticleEndocrinology and metabolism (Seoul, Korea)2021

The Effects of Glucose Lowering Agents on the Secondary Prevention of Coronary Artery Disease in Patients with Type 2 Diabetes.

Inha Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.